CAR- T as well as cellular genetics treatments are too pricey

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production as well as innovation transactions can easily provide cell gene treatments at a cost effective price to patients throughout the world.